Release of ranibizumab using a porous poly(dimethylsiloxane) capsule suppressed laser-induced choroidal neovascularization via the transscleral route.

Journal Information

Full Title: J Mater Sci Mater Med

Abbreviation: J Mater Sci Mater Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"This study was supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine (Japan Agency for Medical Research and Development [AMED]), the Business Incubation Program (Tohoku University, Sendai, Japan), Grant KAKENHI (Ministry of Education, Culture, Sports, Science and Technology-Japan [MEXT], Grant Number: 20K12640) and the START Program (Japan Science and Technology Agency; Grant Number: JPMJST1917)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025